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Abstract
Serum and red blood cell (RBC) total folate are indicators of folate status. No nationally 
representative population data exist for folate forms. We measured serum folate forms [5-
methyltetrahydrofolate (5-methylTHF), unmetabolized folic acid (UMFA), non-methyl folate 
(sum of THF, 5-formylTHF, 5,10-methenylTHF), and MeFox (5-methylTHF oxidation product)] 
by HPLC-MS/MS and RBC total folate by microbiologic assay in US persons ≥1 year (n ~7500) 
participating in the National Health and Nutrition Examination Survey 2011–2. Data analysis for 
serum total folate was conducted including and excluding MeFox. Concentrations (geometric 
mean; detection rate) of 5-methylTHF (37.5 nmol/L; 100%), UMFA (1.21 nmol/L; 99.9%), 
MeFox (1.53 nmol/L; 98.8%), and THF (1.01 nmol/L; 85.2%) were mostly detectable. 5-
FormylTHF (3.6%) and 5,10-methenylTHF (4.4%) were rarely detected. The biggest contributor 
to serum total folate was 5-methylTHF (86.7%); UMFA (4.0%), non-methyl folate (4.7%), and 
MeFox (4.5%) contributed smaller amounts. Age was positively related to MeFox but showed a 
U-shaped pattern for other folates. We generally noted sex and race-ethnic biomarker differences 
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and weak (Spearman r <0.4) but significant (P <0.05) correlations with physiologic and lifestyle 
variables. Fasting, kidney function, smoking, and alcohol intake showed negative associations. 
BMI and body surface area showed positive associations with MeFox but negative associations 
with other folates. All biomarkers showed significantly higher concentrations with recent folic 
acid-containing dietary supplement use. These first-time population data for serum folate forms 
generally show similar associations with demographic, physiologic, and lifestyle variables as 
serum total folate. Patterns observed for MeFox may suggest altered folate metabolism dependent 
on biological characteristics.
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Introduction
The assessment of folate status has a long tradition in the National Health and Nutrition 
Examination Survey (NHANES). It has been carried out since 1974 with the use of different 
measurement procedures and serum and red blood cell (RBC) folate as biomarkers (1). Early 
measurements were conducted by microbiologic assay (1974–1978), followed by two 
variants of a radio protein-binding assay (1978–1991 and 1991–2006), and more recently by 
a much improved microbiologic assay (2007–2010). Folate assays have had continued issues 
with comparability across laboratories and methods, necessitating the adjustment of data to 
allow the assessment of trends over time (1–2). The NHANES 2011–2 survey assessed 
folate status in the US population for the first time by a combination of two analytical 
methods: serum folate forms were measured by HPLC-MS/MS, while whole-blood folate 
was measured by microbiologic assay. RBC folate was then calculated using the data from 
both assays. This approach was the result of a 2010 expert roundtable that advised CDC on 
folate biomarkers and methods for future NHANES surveys (1). It allows clinicians, public 
health practitioners, and researchers to obtain information on the full profile of folate forms 
including unmetabolized folic acid (UMFA). This is important for monitoring purposes in 
the post-fortification era where an extremely low prevalence of folate deficiency is paired 
with higher folic acid intake from dietary supplements (3). HPLC-MS/MS is currently the 
best tool to measure individual folate forms with high sensitivity, specificity, and accuracy 
(1). While this analytical method produced results fully comparable to those of the 
microbiologic assay for serum folate, this was not the case for the more complex analysis of 
whole-blood folate (1). Because these assay differences need to be better understood, 
HPLC-MS/MS was not used for whole blood folate.
Despite the interest in serum folate forms, currently only information on total folate can be 
interpreted clinically in the context of folate status. Clearly, the sum of biologically active 
folate vitamers [5-methyltetrahydrofolate (5-methylTHF), UMFA, tetrahydrofolate (THF), 
5-formyltetrahydrofolate (5-formylTHF), and 5,10-methenyltetrahydrofolate (5,10-
methenylTHF)] constitutes total folate. But it remains to be determined whether MeFox 
(pyrazino-s-triazine derivative of 4α-hydroxy-5-methylTHF) should be included in the 
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calculation of total folate. This compound is an oxidation product of 5-methylTHF that lacks 
vitamin biologic activity (4) and is therefore not captured as part of the total folate 
measurement with the microbiologic assay. While it has been shown that MeFox can be 
formed in vitro after blood collection as a result of suboptimal sample handling (5–6), its 
possible existence in vivo is unclear (5). If the formation of MeFox occurs solely in vitro 
(i.e., after blood collection), then a small part of the formerly active folate pool is lost and 
MeFox should be included in the total folate calculation to avoid underestimating the 
biologically active amount of folate. But if some or all of the MeFox may already be present 
in vivo for an extended period of time, including it in the total folate calculation may slightly 
overestimate the biologically active amount of folate (i.e., folate status will appear better 
than it is because a small part of the total folate is not biologically available).
Our main objective was to describe serum concentrations of several folate forms in the US 
population ≥1 year participating in the NHANES 2011–2 by selected demographic, 
physiologic, and lifestyle variables. Our second objective was to update information on total 
folate status and to provide the first nationally representative data for non-Hispanic Asians. 
We report information on serum total folate with and without the inclusion of MeFox to 
provide much needed insight on this new topic.
Methods
Participants and study design
The NHANES is conducted by the Centers for Disease Control and Prevention (CDC) and 
collects cross-sectional data on the health and nutritional status of the civilian non-
institutionalized US population by use of a stratified, multistage, probability sample design. 
In addition to obtaining information in a home interview setting, participants undergo a 
physical examination and blood draw in a mobile examination center (MEC). In 2011–2, the 
NHANES oversampled Asian and Hispanic persons in addition to oversampling some other 
population groups (7–9). The unweighted response rates for participants ≥1 y of age were 
72.2% for the interview component and 69% for the examination component (10). All 
respondents gave their informed consent, and the NHANES protocol was reviewed and 
approved by the CDC Research Ethics Review Board.
Biomarker measurement
Serum and whole-blood hemolyate samples from participants ≥1 year were analyzed by the 
CDC laboratory for serum folate forms (folate cofactors and MeFox) by use of HPLC-
MS/MS (11–13) and for RBC total folate by use of microbiologic assay (14–16), 
respectively. We did not obtain valid final results for a few samples (<30) resulting in 
different sample sizes among compounds: serum 5-methylTHF (n 7454), UMFA (n 7462), 
THF (n 7461), 5-formylTHF (n 7466), 5,10-methenylTHF (n 7466), MeFox (n 7469), and 
total folate including MeFox (n 7442), and RBC total folate (n 7867). Sample sizes for the 
folate biomarkers by covariate categories are presented in Table 1. Because concentrations 
of the three minor folate forms THF, 5-formylTHF, and 5,10-methenylTHF were often 
below the limit of detection (LOD) and can be a result of folate interconversions at slightly 
acidic pH during sample preparation (17), we calculated the sum of these three forms as 
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non-methyl folate. Serum total folate was calculated as the sum of the six folate forms 
including MeFox. CDC released results <LOD as imputed values (LOD divided by the 
square root of two); we used the imputed values in our calculation when the folate form 
result was <LOD (11). The serum total folate including MeFox result was missing if one of 
the folate forms was missing. We calculated serum total folate excluding MeFox by 
subtracting MeFox from total folate including MeFox. RBC total folate was calculated from 
the measured whole-blood folate concentration after subtracting the serum total folate 
including MeFox concentration (as determined by HPLC-MS/MS) and adjusting for RBC 
volume (15). Assay performance is summarized in the online supplementary Table S1 and 
has been described previously with regard to international reference materials for the HPLC-
MS/MS (1,18) and microbiologic assay (14).
Study variables
We categorized the demographic variables as follows: age (1–5, 6–11, 12–19, 20–39, 40–59, 
and ≥60 years), sex (males and females), and race-ethnicity [Hispanic (Mexican American + 
other Hispanic), non-Hispanic Asian, non-Hispanic Black, and non-Hispanic White; other 
racial-ethnic groups were included in overall estimates]. We also reported separate estimates 
for Mexican Americans to allow comparison to previous reports. We examined physiologic 
and lifestyle variables previously shown to be associated with folate concentrations (19–20): 
fasting time (<3, 3–<8, and ≥8 hours), kidney function as determined by estimated 
glomerular filtration rate [eGFR; 0–<60, 60–<90, and ≥90 mL/(min×1.73 m2)] (21), BMI 
[<18.5 (underweight), 18.5–<25 (normal), 25–<30 (overweight), and ≥30 kg/m2 (obese)] 
(22), body surface area (BSA, calculated as square root of (height in cm × weight in kg/
3600); <1.5, 1.5–<1.8, 1.8–<2.0, and ≥2.0 m2) (23), smoking [serum cotinine ≤10 μg/L 
(nonsmoker) and >10 μg/L (smoker)] (24), alcohol intake [average daily number of 
“standard” drinks (1 drink ~15 g alcohol): no drinks, <1 (not 0), 1–<2, and ≥2 drinks/day; 
only available for participants ≥18 years] (19), and use of folic acid-containing dietary 
supplements [self-reported use during the 24 hours prior to visiting the MEC (self-reported 
use during the last 30 days is no longer available in NHANES 2011–2); yes and no]. We 
presented the association between folate concentrations and body size by two variables: 
BMI, used traditionally in nutrition studies, and BSA, used in exposure studies to provide 
insight on “body burden”. A BSA value <1.5 m2 generally represents children, while a value 
≥2.0 m2 generally represents adult men. This additional variable may shed light on the 
distinction between metabolism vs. “dilution effects” due to body size.
Statistical analysis
We applied no exclusion criteria to our data analysis and used pairwise deletion for missing 
values in a particular analysis. We used the MEC weights to account for differential 
nonresponse or noncoverage and to adjust for oversampling of some groups. We calculated 
the mean percent contribution of each folate form to serum total folate including MeFox. We 
also calculated the mean absolute and percent contribution of each folate form to serum total 
folate including MeFox by weighted decile of serum total folate including MeFox. Bivariate 
associations between geometric mean folate biomarker concentrations (to normalize for 
right-skewed distributions) and each study variable were described. Geometric means were 
compared across the categories without (Wald F P value) and with (Satterthwaite F P value) 
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controlling for additional covariates (age, sex, and race-ethnicity). We used Spearman 
coefficients to assess pairwise correlations among folate biomarkers as well as between 
folate biomarkers and selected physiologic and lifestyle variables. We assessed the 
distributions [geometric means and selected percentiles (95% CI)] for each folate biomarker 
among all participants, fasted (≥8 hours) participants, and nonfasted (<8 hours) participants 
≥1 year by demographic variables. Significance was defined as a two-sided P value of 
<0.05. Statistical analyses were performed using SAS (version 9, SAS Institute Inc., Cary, 
NC) and SUDAAN (version 9.2, RTI, Research Triangle Park, NC) software.
Results
A summary of the characteristics of the study population for each variable of interest is 
given in the online supplementary Table S2. Among US persons ≥1 year in the unweighted 
NHANES 2011–2 sample, 27% were children (1–11 years), 14% were adolescents (12–19 
years), and 59% were adults (≥20 years). Half of the participants were female and almost 
one-third were non-Hispanic white. Nearly half (43%) of the participants were fasted for ≥8 
hours, 8% had an impaired eGFR (<60 mL/min/1.73 m2), 24% were obese, 30% had a small 
BSA (<1.5 m2), 17% were considered smokers (serum cotinine concentrations >10 μg/L), 
one-third of participants ≥18 years reported not consuming any alcoholic beverage, and 
about 20% of participants reported using folic acid-containing dietary supplements during 
the last 24 hours.
Folate biomarker concentrations and contribution of folate forms to serum total folate
The concentration ranges of serum total folate excluding MeFox, serum total folate 
including MeFox, and RBC total folate were 3.26–375, 3.50–377, and 149–5490 nmol/L, 
respectively. Concentration ranges (nmol/L) of serum folate forms were: 1.88–295 for 5-
methylTHF, <LOD (0.14)–282 for UMFA, <LOD (0.37)–11.5 for THF, <LOD (0.30)–31.6 
for 5-formylTHF, <LOD (0.34)–4.38 for 5,10-methenylTHF, and <LOD (0.34)–20.4 for 
MeFox. Concentrations of 5-methylTHF (100%), UMFA (99.9%), MeFox (98.8%), and 
THF (85.2%) were detectable in all or most samples, while concentrations of 5-formylTHF 
(3.6%) and 5,10-methenylTHF (4.4%) were detectable in only a few samples.
On average, 5-methylTHF (86.7%) was the biggest contributor to serum total folate 
including MeFox, while UMFA (4.0%), non-methyl folate (4.7%), and MeFox (4.5%) 
contributed smaller amounts. When we calculated the contribution of these folate forms by 
decile of serum total folate including MeFox (Fig. 1 and online supplementary Table S3), 
we noted some fluctuation in the proportion of 5-methylTHF (79.9–90.2%), a decreasing 
proportion of non-methyl folate (9.1% in the first, 2.8% in the last decile) and MeFox (6.6% 
in the first, 3.0% in the last decile), and a generally U-shaped proportion of UMFA (4.5% in 
the first, ~3% in the fifth, and 10.4% in the last decile) with increasing decile of serum total 
folate including MeFox.
Folate biomarker concentrations by demographic characteristics
We noted close to U-shaped age patterns for all serum folate forms except MeFox, for which 
the concentration was significantly higher in persons ≥60 years compared to all other age 
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groups and the proportion of MeFox relative to serum total folate including MeFox was 
significantly higher in persons ≥60 years compared to the three youngest age groups (Table 
2 and online supplementary Fig. 1). Age was a significant factor for all serum folate forms 
as well as for serum total folate including and excluding MeFox, and RBC total folate 
whether or not we controlled for other demographic covariates (sex and race-ethnicity). 
While females had significantly higher serum total folate including and excluding MeFox, 
RBC total folate, 5-methylTHF, and UMFA concentrations with and without controlling for 
age and race-ethnicity, there were no sex differences for non-methyl folate and MeFox 
concentrations. All folate biomarker concentrations except non-methyl folate varied 
significantly by race-ethnicity, with non-Hispanic whites having the highest concentrations 
and non-Hispanic Asians having similar concentrations compared to Hispanics. These 
observations did not change after we controlled for age and sex. The concentration 
difference between geometric means of serum total folate excluding vs. including MeFox 
was ~2 nmol/L and it was reasonably consistent across demographic groups.
Correlations among folate biomarkers
Spearman correlations were significant for most pairwise comparisons of folate biomarkers 
in persons ≥1 year (see online supplementary Table S4). We observed significant and strong 
(r ≥0.7) correlations for 5-methylTHF with serum total folate including MeFox (r = 0.99) 
and for THF with non-methyl folate (r = 1.0). We observed significant and moderate (0.4 ≤ r 
< 0.7) correlations for 5-methylTHF with RBC total folate (r = 0.59), for UMFA with 5-
methylTHF (r = 0.44) and serum total folate including MeFox (r = 0.50), and for serum total 
folate including MeFox with RBC total folate (r = 0.59). We observed significant but weak 
(r <0.4) correlations for 5-methylTHF with MeFox (r = 0.25). After stratifying by age 
group, we noted a strengthening of the correlations in persons ≥60 years (trace covered a 
larger area than for persons 1–19 or 20–59 years), but the same patterns overall (Fig. 2).
Associations between folate biomarkers and selected physiologic and lifestyle 
characteristics
We observed generally significant but weak Spearman correlations between folate 
biomarkers and the continuous physiologic and lifestyle variables (Table 3). Fasting, kidney 
function, smoking, and alcohol intake were negatively associated with most folate 
biomarkers. BMI and body surface area showed positive associations with MeFox and 
negative associations with other folates. We noted generally significant differences in 
concentrations between the levels of the categorical variables, including categorized 
versions of the physiologic and lifestyle variables, whether or not we controlled for 
demographic covariates (age, sex, and race-ethnicity) (Table 4). All folate biomarkers 
showed significantly higher concentrations with recent folic acid-containing dietary 
supplement use whether or not we controlled for demographic covariates. The concentration 
difference between serum total folate excluding vs. including MeFox was ~2 nmol/L and it 
was again reasonably consistent across categories of variables.
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Reference intervals and distributions of folate biomarker concentrations
Because fasting was a significant factor for most folate biomarkers, we calculated the central 
95% reference intervals (2.5th – 97.5th percentile) for all, fasted, and nonfasted “generally 
healthy” persons ≥1 year (Table 5). Reference intervals were fairly comparable among these 
three groups for 5-methylTHF, non-methyl folate, serum total folate excluding and including 
MeFox, and RBC total folate. However, we noted a lower upper end of the reference 
interval in fasted persons for UMFA and MeFox.
Selected percentiles (5th to 95th) presented by age, sex, and race-ethnicity for all, fasted, and 
nonfasted persons ≥1 year generally showed the greatest variation by age group (see online 
supplementary Tables S5–S11). We observed distinct differences in the distributions of 
serum total folate excluding and including MeFox, RBC total folate, and 5-methylTHF by 
age group. We also observed differences in the upper end of the distribution of UMFA by 
age group, higher non-methyl folate concentrations at the lower end of the distribution for 
children 1–5 years compared to any other age group, and a right-shift in the distribution of 
MeFox with increasing age group. The differences we observed in the central 95% reference 
intervals between all and fasted persons were also notable in the entire distribution of folate 
concentrations.
Folate status time trend
Serum total folate excluding MeFox concentrations [geometric mean (95% CI)] were similar 
in 2011–2 [41.4 (40.1–42.9) nmol/L] compared to the previous two survey cycles, when the 
microbiologic assay was used, which does not respond to MeFox: 2007–8 [39.5 (37.7–41.3) 
nmol/L] and 2009–0 [38.2 (37.2–39.3) nmol/L]. RBC total folate concentrations measured 
in all three survey cycles by microbiologic assay also appeared to be similar: 2007–8 [1120 
(1070–1160) nmol/L], 2009–0 [1040 (1010–1070) nmol/L], and 2011–2 [1050 (1010–1090) 
nmol/L]. As in the previous two survey cycles, <1% of the US population in NHANES 
2011–2 had serum (<10 nmol/L) or RBC total folate (<340 nmol/L) concentrations at risk 
for deficiency (25).
Discussion
This study provides the first national reference information for serum folate forms measured 
by HPLC-MS/MS in a population exposed to folic acid fortification. It also offers a better 
understanding of variables associated with concentrations of serum folate forms. Based on 
the newest serum and RBC total folate concentrations from NHANES 2011–2, the folate 
status of the US population was comparable to previous years and non-Hispanic Asians had 
similar folate concentrations compared to Hispanics.
Previous studies that assessed the profile of serum folate forms used convenience samples 
and were small in size (mostly <100 subjects). Most studies investigated special population 
subgroups such as pregnant women, older adults, or hemodialysis patients (26–30), while a 
few studies measured serum folate forms in apparently healthy US, German, or Norwegian 
adults, though generally as part of method validations (5,17,31–34). Given that the 
population in this study was exposed to folic acid fortification and known to have a 
Pfeiffer et al. Page 7













historical prevalence of folic acid supplement use of ~35% (35), the higher 5-methylTHF 
(38.5 nmol/L) and UMFA (0.991 nmol/L) median concentrations compared to the small 
convenience sample reports for German [15.8 nmol/L and 0.10 nmol/L, respectively, (34)] 
or Norwegian [16.4 nmol/L and 0.0 nmol/L, respectively, (54)] adults from countries with 
no folic acid fortification were not surprising. However, caution should be used when 
comparing data from different populations, in part due to potential method differences that 
have historically plagued folate analyses (36).
The 5-methylTHF concentration was the biggest and a constant contributor to serum total 
folate regardless of the population [86.7% in US (this study) compared to 87.2% in German 
(34) and 85.8% in Norwegian persons (5)]. The higher mean UMFA concentration (13.5 
nmol/L) and relative contribution (10.2%) in the highest decile of serum total folate 
including MeFox compared to the lower deciles (0.78–2.87 nmol/L, 2.75–4.45%) in this 
study is likely due to the larger intake of folic acid from dietary supplements and/or fortified 
foods and the incomplete conversion of folic acid to 5-methylTHF upon absorption (37–39). 
A previous report from NHANES 2007–8 showed that UMFA concentrations >1 nmol/L 
were largely explained by total folic acid intake from diet and supplements apart from 
fasting status (40). Not surprisingly, we found significantly higher serum folate forms as 
well as serum and RBC total folate concentrations in persons who reported consuming folic 
acid-containing dietary supplements during the last 24 hours.
Given that MeFox is an oxidation product of 5-methylTHF, the correlation between these 
two folate forms (r = 0.25) was lower than expected. This may indicate that factors beyond 
the amount of circulating 5-methylTHF may influence the generation of MeFox. Thus, the 
relevance of MeFox in relation to folate status is likely of interest in any population, 
regardless of whether they have high folate status as a result of fortification or 
supplementation or not. The high correlations between 5-methylTHF and serum total folate 
(r = 0.99) and between THF and non-methyl folate (r = 1.00) were expected, as these two 
folate forms were the major contributors to serum total folate and non-methyl folate, 
respectively. We found a correlation between UMFA and 5-methylTHF (r = 0.54 for 
persons ≥60 y) similar to that reported for older German adults (r = 0.42 at baseline and r = 
0.56 after supplementation with folic acid) (30). We found lower correlations between 
UMFA and THF (r = 0.22) or between 5-methylTHF and THF (r = 0.30) in US older 
persons compared to the report in German older adults (at baseline: r = 0.39 and r = 0.51, 
respectively; after supplementation: r = 0.45 and r = 0.56, respectively) (30).
Among demographic variables studied, we found interesting patterns with age. While most 
folate forms displayed the typical U-shaped age pattern previously documented with serum 
and RBC total folate (41), concentrations of MeFox showed a linear pattern and were 
highest in persons ≥60 years. The distribution of MeFox concentrations showed a right-shift 
with increasing age group resulting in higher detection rates of MeFox in persons ≥60 years 
(99.7% compared to 95.5% in children 1–5 years). Conversely, detection rates of THF were 
highest in children 1–5 years (96.1% compared to 82.9–89.1% for other age groups). These 
observations may indicate altered folate metabolism, possibly as a result of aging, and will 
have to be confirmed in other studies. It is interesting though to note that older age was 
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associated with less bioactive folate (THF) and more biologically inactive folate (MeFox), 
possibly pointing to an increased catabolism.
The associations of serum folate forms with physiologic and lifestyle variables were 
generally consistent with reports for serum total folate from NHANES 2003–6 (19–20). 
While most serum folate forms showed higher concentrations in nonfasted persons, we 
found no difference in RBC total folate concentrations by fasting time, consistent with the 
prevailing knowledge that RBC total folate concentrations are not affected by fasting (42). 
The negative association of serum folate forms and of serum and RBC total folate with 
decreasing kidney function was no longer significant for several folate biomarkers (5-
methylTHF, non-methyl folate, total folate excluding and including MeFox) after we 
controlled for demographic covariates. Most serum folate forms showed lower 
concentrations in smokers and in persons with higher alcohol intake.
Some observations with physiologic and lifestyle variables, particularly for MeFox, were 
unexpected and may indicate altered folate metabolism, possibly challenging the notion that 
MeFox occurs solely in vitro. BMI and BSA were positively associated with MeFox, but 
negatively with 5-methylTHF concentrations. This is counterintuitive if one assumes that 
higher 5-methylTHF concentrations will lead to higher MeFox concentrations. It may in fact 
indicate a greater “loss” of active folate in obesity. Whether this has any bearing on 
epidemiologic observations linking obesity with a higher rate of neural tube defects (43) is 
unclear, particularly if one considers that in our study obese vs. normal weight persons had 
~5.5 nmol/L lower 5-methylTHF, but only ~0.2 nmol/L higher MeFox concentrations. We 
need a better understanding of these relationships to appropriately interpret them. The lower 
serum total folate (and higher RBC total folate) concentrations reported previously with 
higher BMI led to the hypothesis that cellular uptake and tissue distribution of folate may be 
altered by BMI (44). The current data by BSA category may instead imply a “dilution 
effect” whereby most folate forms and serum total folate concentrations were lower in larger 
persons. This interpretation was also consistent with the finding that children <11 years had 
higher 5-methylTHF and serum total folate concentrations compared to all other age groups.
We found a median MeFox concentration (1.49 nmol/L) similar to that reported in 
Norwegian adults [2.3 nmol/L; the authors called this compound 4α-hydroxy-5-methylTHF 
but stated that it was the pyrazino-s-triazine derivative, (5)], suggesting that concentrations 
of this oxidation product are low as long as the blood is processed under controlled 
conditions. Yet, we found apparent inconsistencies regarding MeFox and 5-methylTHF 
concentrations (Table 5) which raised the possibility that MeFox may be formed in vivo 
rather than solely in vitro as part of 5-methylTHF oxidation. In rats, administration of radio-
labeled folic acid resulted in the excretion of several labeled products: a precursor of MeFox 
(4-α-hydroxy-5-methylTHF), 5-methylTHF, 10-formyl-folic acid, and p-aminobenzoyl-L-
glutamate, a folate breakdown product (45). It is therefore conceivable that a small portion 
of MeFox measured in serum may already be in circulation at the time of the blood draw. 
We know that MeFox can be formed during the pre-analytical phase (blood collection and 
processing) (5–6), leading to a small loss of “active” folate after blood is collected. We have 
shown that the analytical phase of the CDC LC-MS/MS method does not generate additional 
MeFox (11). Thus, it appears that failure to include MeFox as part of serum total folate may 
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slightly underestimate folate status if MeFox is mostly formed in vitro, while including it 
may slightly overestimate folate status if MeFox is mostly formed in vivo. Mechanistic 
studies that further explore the origins of this oxidation product are needed.
Our study is subject to some limitations. The data are based on only one NHANES survey 
period limiting our ability to generalize findings for some stratifications. While we evaluated 
the association of folate biomarkers with recent use of folic acid-containing dietary 
supplements as part of selected lifestyle factors, evaluating dietary folate intake overall and 
according to intake sources (fortified cereal-grain foods, ready-to-eat cereals, supplements, 
and combinations thereof) was beyond the scope of this study. Lastly, because these are the 
first national estimates of folate vitamers, we are limited in our ability to compare findings 
to other studies of similar magnitude.
In summary, these novel data on serum folate forms generally show associations between 
these compounds and selected demographic, physiologic, and lifestyle variables similar to 
those reported previously for serum total folate. However, particularly for MeFox, we 
observed distinct patterns with the variables studied that may suggest altered folate 
metabolism dependent on biological characteristics. Thus, measuring MeFox as part of the 
folate profile may provide relevant information in populations with high or low folate status. 
While we cannot as yet answer the question of whether it is more accurate to include or 
exclude MeFox from the total folate, the difference between the two approaches is rather 
small (~5%). Based on the findings of this study and for practical reasons we suggest that 
until an unequivocal answer is found, MeFox should NOT be included in the calculation of 
serum total folate, but should be separately reported to allow an assessment of the quality of 
sample handling as well as potential insight into folate metabolism. This approach has two 
advantages: the total folate without MeFox can be directly compared to the microbiologic 
assay and other assays that do not measure this biologically inactive form and one errs on 
the side of caution with the interpretation of folate status by slightly underestimating it. The 
new reference intervals for serum folate forms in a population that has been exposed to folic 
acid fortification for over 15 years provide a much-needed benchmark to researchers and 
public health officials in those nations in which folic acid fortification has already occurred 
(e.g., the United States, Canada) and where folic acid intakes are significant contributors to 
total folate intakes, but also to nations that consider folic acid fortification (e.g., the United 
Kingdom).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Mean absolute (panel a) and relative (panel b) contribution of folate forms to serum total 
folate by weighted decile of serum total folate in the US population ≥1 year, NHANES 
2011–2. Serum folate forms and serum total folate (sum of folate forms including MeFox) 
were measured by HPLC-MS/MS. Non-methyl folate represents the sum of three minor 
forms tetrahydrofolate, 5-formyltetrahydrofolate and 5,10-methenyltetrahydrofolate. 5-
MethylTHF, 5-methyltetrahydrofolate; MeFox, pyrazino-s-triazine derivative of 4α-
hydroxy-5-methylTHF; UMFA, unmetabolized folic acid.
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Spearman correlation between various folate biomarkers by age group in the US population 
≥1 y, NHANES 2011–2. Only statistically significant correlations are shown (see 
supplementary Table S4 for complete information). Serum folate forms and serum total 
folate (sum of folate forms including MeFox) were measured by HPLC-MS/MS. Non-
methyl folate represents sum of three minor forms: tetrahydrofolate, 5-
formyltetrahydrofolate and 5,10-methenyltetrahydrofolate. RBC total folate was measured 
by microbiologic assay. 5-MethylTHF, 5-methyltetrahydrofolate; FOL, folate; MeFox, 
pyrazino-s-triazine derivative of 4α-hydroxy-5-methylTHF; RBC, red blood cell; UMFA, 
unmetabolized folic acid.
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Table 6






Unexpectedly low (r = 0.25) considering that MeFox is an oxidation product of 5-methylTHF
Age MeFox concentrations seemed to increase linearly with age while 5-methylTHF concentrations showed a U-shaped 
age pattern
Sex MeFox concentrations did not differ by sex while 5-methylTHF concentrations were higher in females
Fasting status MeFox concentrations were much lower in fasted (≥8 hours) compared to nonfasted (<3 hours) persons (39%) while 
5-methylTHF concentrations were only a little bit lower (7%); the central 95% reference intervals for serum total 
folate excluding and including MeFox were almost the same in fasted persons, but not in nonfasted persons
Kidney function MeFox concentrations were much higher (111%) in persons with poor (eGFR <60 mL/(min×1.73 m2) compared to 
good (eGFR ≥90 mL/(min×1.73 m2) kidney function while 5-methylTHF concentrations were only a little bit higher 
(22%)
BMI MeFox concentrations were higher (21%) with higher BMI (obese vs. underweight) while 5-methylTHF 
concentrations were lower (32%)
BSA MeFox concentrations were higher (11%) with higher BSA (≥2 vs. <1.5 cm×kg) while 5-methylTHF concentrations 
were lower (34%)
Smoking status MeFox concentrations did not differ by smoking status while 5-methylTHF concentrations were lower (26%) in 
smokers
MeFox, pyrazino-s-triazine derivative of 4α-hydroxy-5-methylTHF; NHANES, National Health and Nutrition Examination Survey; 5-methylTHF, 
5-methyltetrahydrofolate; eGFR, estimated glomerular filtration rate; BSA, body surface area.
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